Quanterix Corporation Announces Date of 2026 Annual Meeting Quanterix Corporation Announces Date of 2026 Annual Meeting - Share BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection (the "Company†), today announced that the Company's 2026 annual meeting of shareholders (the "Annual Meeting†) will be held virtually, by means of remote communication, on Tuesday, June 9, 2026 at 10:00 am Eastern Time. Stoc ...

CALGARY, AB – TheNewswire - March 26, 2026 - nDatalyze Corp. (CSE: NDAT) (OTC: NDATF) (the "Company" or "nDatalyze") is pleased to announce its intention to participate in the Semi-Annual Reporting ("SAR") Pilot Program recently adopted by the Canadian Securities Administrators (CSA), provides a progress report on the potential RTO, and updates the Epitome sports performance assessment project. The SAR Pilot: Implemented through Coordinated Blanket Order 51-933, allows eligible venture issuers listed on th ...

Performance was driven by a distribution-led model that expanded the partner network by 34% to 858 brokers and TPAs, though management notes penetration remains below 0.1% of the total U.S. broker market. The company successfully transitioned up-market by extending its EDIBS platform to support employers with over 100 employees, moving beyond its initial small-group focus. Operational efficiency is anchored by compressing underwriting timelines for large employers from approximately three months to ro ...

Claritev Cares Opens Rural Health Grants, Continuing Three Decades of Investment in Underserved Communities Mar 25, 2026 12:00 PM Eastern Daylight Time Claritev Cares Opens Rural Health Grants, Continuing Three Decades of Investment in Underserved Communities Share Expanding Access to Healthcare and Strengthen Community Impact MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more tr ...

LANDER, Wyo., March 24, 2026 (GLOBE NEWSWIRE) -- VGTEL, Inc. (OTC: VGTL) announced today that it has entered formal strategic discussions with Bell Rose Capital Inc. (OTC: BELR) regarding the potential acquisition of a next-generation health-technology application developed by 4biddenknowledge Inc., a wholly owned subsidiary of Bell Rose. The health-tech app, a pre-revenue but high-potential digital wellness platform, represents a new class of emerging health technology designed to support users through adv ...

Core Insights - Innovaccer has launched Galaxy UM, an AI-powered utilization management platform aimed at automating prior authorization processes for health plans, thereby reducing administrative costs and improving care delivery outcomes [1][3][4] Group 1: Challenges in Utilization Management - Prior authorization is a complex and resource-intensive process, often relying on manual workflows, which leads to delays in care and increased operational costs for payers [2] - New regulatory requirements are increasing pressure on health plans to meet stricter turnaround timelines and reporting standards [2] Group 2: Features of Galaxy UM - Galaxy UM automates the entire utilization management lifecycle, allowing health plans to receive requests from multiple channels, structure clinical data, evaluate medical necessity, and communicate decisions in real time [3][4] - The platform employs advanced natural language processing and optical character recognition to analyze unstructured clinical documents, facilitating faster and more accurate case evaluations [4] Group 3: Commitment to Clinical Oversight - Galaxy UM follows an "only auto-approve, never auto-deny" approach, ensuring cases needing further review are directed to qualified clinicians, which enhances transparency and trust among members, payers, and providers [5] Group 4: Compliance and Data Integration - The platform is designed to support compliance with evolving regulatory requirements, including CMS-0057, by providing automated turnaround tracking and comprehensive audit trails [6] - Built on Innovaccer's Health Cloud, Galaxy UM enables unified access to clinical, claims, and operational data, improving decision accuracy and helping organizations identify avoidable utilization [6] Group 5: Availability - Galaxy UM is currently in limited beta testing, with general availability expected later in 2026 [7]

Tempus AI, Inc. (NASDAQ:TEM) is among the 10 Best New AI Stocks to Buy. On March 9, H.C. Wainwright analyst Yi Chen raised the firm’s price target on Tempus AI, Inc. (NASDAQ:TEM) to $95 from $89 while maintaining a Buy rating. The analyst highlighted the company’s expanding network of strategic partnerships, including collaborations with Merck & Co., Median Technologies, and NYU Langone Health, which are advancing precision medicine and AI-driven diagnostics. These partnerships enhance the company’s data ...

Core Insights - Wolters Kluwer Health has integrated Continuing Medical Education (CME) credits into the UpToDate Expert AI platform, allowing clinicians to earn credits while engaging with the AI during clinical decision-making [1][2][3] Group 1: CME Integration - The integration of CME credits aims to reduce the administrative burden on healthcare professionals and support continuous learning in clinical settings [2] - Clinicians can earn and track CME credits as part of their routine point-of-care decision-making, enhancing their engagement with emerging evidence and standards of care [1][2] Group 2: AI and Clinical Practice - UpToDate Expert AI provides generative AI responses based on evidence-based, physician-authored content, ensuring that the information is reliable and relevant [2][4] - The initiative reflects a commitment to making continuing education more accessible and integrated into clinical practice, emphasizing the importance of AI in supporting both clinical decision-making and professional development [4] Group 3: Accreditation and Compliance - UpToDate is accredited by the Accreditation Council for Continuing Medical Education (ACCME), ensuring that the education provided is relevant, evidence-based, and independent of commercial influence [4] - CME credits earned through UpToDate Expert AI can be shared electronically for relicensure and recertification, allowing clinicians to focus more on learning rather than administrative tasks [3]

Core Insights - The Doximity report reveals that 94% of physicians are currently using or interested in using AI, but 71% express concerns regarding its accuracy and reliability [1][2]. Group 1: AI Adoption and Usage - AI adoption among physicians has significantly increased, with usage rising from 47% in April 2025 to 63% in January 2026, marking a 16-point increase [3]. - Neurologists have the highest AI adoption rate at 64%, followed by gastroenterologists at 61% and internists at 60% [3]. - One-third (37%) of physicians reported using AI at least daily, while 54% of all surveyed physicians indicated they use AI in their practice [3]. Group 2: Benefits of AI - AI is perceived to help reduce administrative burdens, with 90% of physicians believing it can decrease "pajama time," the after-hours work contributing to burnout [6]. - Two-thirds (69%) of AI users reported improvements in patient care and outcomes, and 75% noted a reduction in administrative workload and an increase in job satisfaction [6]. Group 3: Specific AI Applications - Voice-based documentation, including ambient listening and AI scribes, increased from 20% to 29% among physicians over the study periods [3]. - Literature search emerged as the most common AI use case, rising from 22% in April 2025 to 35% in January 2026 [3].

Core Viewpoint - AI Maverick Intel, Inc. has entered into a Right of First Refusal Agreement with HEAL Group Holdings Inc., allowing AIMV to acquire certain business units or assets of HEAL under specified conditions, effective February 11, 2026 [1] Group 1: Agreement Details - The agreement grants AIMV the right to review and match bona fide offers from third parties for specific assets or business units of HEAL during a defined exercise period [1] - AIMV will issue 120,000,000 common shares to HEAL at a deemed price of US$0.02 per share, totaling US$2.4 million as consideration for the right of first refusal [1] - The right of first refusal will remain effective for three years unless terminated earlier by mutual agreement [1] Group 2: Strategic Rationale - The agreement provides AIMV with structured access to potential acquisition opportunities within HEAL's portfolio of AI-driven healthcare technology and services across more than six countries [1] - AIMV aims to evaluate and potentially participate in transactions involving digital health platforms and related operating businesses as opportunities arise [1] - The agreement allows AIMV to maintain flexibility in its broader capital markets and acquisition strategy while evaluating strategic opportunities within the HEAL ecosystem [1] Group 3: Company Background - AI Maverick Intel, Inc. focuses on identifying and developing opportunities at the intersection of artificial intelligence, data platforms, and emerging technology-enabled industries [1] - HEAL Group Holdings Inc. is a privately held health technology and wellness platform company, backed by approximately US$75 million of family office capital, with a portfolio of around 25 entities across North America and Europe [1] - The HEAL ecosystem includes virtual healthcare platforms, mental health and pain management clinics, pharmaceutical distribution infrastructure, and digital health technologies [1]